Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics Prime
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Dr Hoenle Aktiengesellschaft Comments on FY 2013 Sales and Operating Result Guidance


Thursday, 22 Aug 2013 10:59pm EDT 

Dr Hoenle Aktiengesellschaft announced that starting with its previous statement that sales of between EUR 75 and 80 million and an operating result of between EUR 8 and 9 million will be achieved, the Hoenle Group Management presently assumes that the respective lower limits of the target corridors will be reached in fiscal year 2013. According to I/B/E/S estimates, analysts on average are expecting the Company to report fiscal year 2013 revenue of EUR 75.8 million and EBIT of EUR 8.2 million. 

Company Quote

15.5
0.04 +0.26%
15 Aug 2014